ziprasidone has been researched along with Autism in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brugnoli, R; Carlino, N; D'Andreagiovanni, M; De Giorgi, R; Del Casale, A; Giardini, M; Girardi, P; Kotzalidis, GD; Rapinesi, C; Sacco, M | 1 |
| Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA | 1 |
| Kem, DL; McDougle, CJ; Posey, DJ | 1 |
| Alessi, NE | 1 |
| Cohen, SA; Fitzgerald, BJ; Khan, A; Khan, SR | 1 |
| Keck, PE; Strawn, JR | 1 |
| Duggal, HS | 1 |
| Cater, JR; Delaney, MA; Hyman, SB; Malone, RP | 1 |
1 review(s) available for ziprasidone and Autism
| Article | Year |
|---|---|
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles | 2008 |
1 trial(s) available for ziprasidone and Autism
| Article | Year |
|---|---|
The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.
Topics: Adult; Age Factors; Antipsychotic Agents; Autistic Disorder; Cholesterol; Female; Humans; Male; Middle Aged; Piperazines; Retrospective Studies; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
6 other study(ies) available for ziprasidone and Autism
| Article | Year |
|---|---|
Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
Topics: Adult; Antipsychotic Agents; Autistic Disorder; Comorbidity; Gilbert Disease; Humans; Intellectual Disability; Male; Piperazines; Psychotic Disorders; Risperidone; Thiazoles | 2016 |
Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
Topics: Adolescent; Adult; Aggression; Autistic Disorder; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Irritable Mood; Male; Piperazines; Psychomotor Agitation; Serotonin Antagonists; Thiazoles | 2002 |
Ziprasidone in autism.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Bipolar Disorder; Comorbidity; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Thiazoles | 2003 |
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Fluid Therapy; Haloperidol; Humans; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Piperazines; Self-Injurious Behavior; Sodium Bicarbonate; Thiazoles | 2006 |
Ziprasidone for maladaptive behavior and attention-deficit/hyperactivity disorder symptoms in autistic disorder.
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child Behavior Disorders; Humans; Male; Piperazines; Thiazoles | 2007 |
Ziprasidone in adolescents with autism: an open-label pilot study.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Child; Cholesterol; Dose-Response Relationship, Drug; Dystonia; Electrocardiography; Female; Humans; Male; Pilot Projects; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Thiazoles; Treatment Outcome; Weight Gain | 2007 |